Table 1.
Clinical characteristics | CHB+ study cohort (n=16) | CHB− control cohort (n=65) | p Value |
---|---|---|---|
Mean age±SD | 32.7±5.2 | 34.4±4.52 | 0.35 |
Diseases | |||
Sjögren’s syndrome | 5 | 26 | 0.72 |
Undifferentiated connective tissue disease | 3 | 20 | 0.52 |
Systemic lupus erythematosus | 0 | 3 | 0.89 |
Rheumatoid arthritis | 0 | 1 | 0.44 |
Discoid lupus | 0 | 1 | 0.44 |
Antiphospholipid syndrome | 0 | 2 | 0.85 |
Asymptomatic women | 8 | 12 | 0.02* |
Thyroiditis† | 4 | 8 | 0.37 |
*Statistically significant difference.
†Alone or associated.
CHB+, congenital heart block outcome; CHB−, normal pregnancy outcome.